Streamline Health Solutions Stock Fundamentals
| STRM Stock | USD 3.07 0.07 2.23% |
Streamline Health Solutions fundamentals help investors to digest information that contributes to Streamline Health's financial success or failures. It also enables traders to predict the movement of Streamline Stock. The fundamental analysis module provides a way to measure Streamline Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Streamline Health stock.
At this time, Streamline Health's Other Operating Expenses is very stable compared to the past year. As of the 15th of March 2025, Total Operating Expenses is likely to grow to about 37.7 M, while Total Revenue is likely to drop about 19.1 M. Streamline | Select Account or Indicator |
Streamline Health Solutions Company Return On Equity Analysis
Streamline Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Streamline Health Return On Equity | -0.8 |
Most of Streamline Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Streamline Health Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Streamline Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Streamline Health Solutions has a Return On Equity of -0.8009. This is 96.66% lower than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 158.35% higher than that of the company.
Streamline Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Streamline Health's current stock value. Our valuation model uses many indicators to compare Streamline Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Streamline Health competition to find correlations between indicators driving Streamline Health's intrinsic value. More Info.Streamline Health Solutions is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Streamline Health's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Streamline Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Streamline Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Streamline Health's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Streamline Health could also be used in its relative valuation, which is a method of valuing Streamline Health by comparing valuation metrics of similar companies.Streamline Health is currently under evaluation in return on equity category among its peers.
Streamline Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Streamline Health from analyzing Streamline Health's financial statements. These drivers represent accounts that assess Streamline Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Streamline Health's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 913.6M | 879.9M | 1.6B | 22.0M | 19.8M | 18.8M | |
| Enterprise Value | 913.9M | 880.1M | 1.6B | 29.4M | 26.5M | 25.1M |
Streamline Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Streamline Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Streamline Health's managers, analysts, and investors.Environmental | Governance | Social |
Streamline Fundamentals
| Return On Equity | -0.8 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.93) % | ||||
| Operating Margin | (0.71) % | ||||
| Current Valuation | 24.63 M | ||||
| Shares Outstanding | 4.27 M | ||||
| Shares Owned By Insiders | 24.21 % | ||||
| Shares Owned By Institutions | 20.37 % | ||||
| Number Of Shares Shorted | 21.76 K | ||||
| Price To Earning | 321.67 X | ||||
| Price To Book | 0.94 X | ||||
| Price To Sales | 0.71 X | ||||
| Revenue | 22.6 M | ||||
| Gross Profit | 11.49 M | ||||
| EBITDA | (12.82 M) | ||||
| Net Income | (18.7 M) | ||||
| Cash And Equivalents | 5.92 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 10.57 M | ||||
| Debt To Equity | 0.35 % | ||||
| Current Ratio | 0.76 X | ||||
| Book Value Per Share | 0.75 X | ||||
| Cash Flow From Operations | (2.21 M) | ||||
| Short Ratio | 0.62 X | ||||
| Earnings Per Share | (2.35) X | ||||
| Price To Earnings To Growth | (0.44) X | ||||
| Target Price | 22.5 | ||||
| Number Of Employees | 77 | ||||
| Beta | 1.64 | ||||
| Market Capitalization | 15.34 M | ||||
| Total Asset | 41.73 M | ||||
| Retained Earnings | (115.7 M) | ||||
| Working Capital | (4.85 M) | ||||
| Current Asset | 16.2 M | ||||
| Current Liabilities | 14.11 M | ||||
| Net Asset | 41.73 M |
About Streamline Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Streamline Health Solutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Streamline Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Streamline Health Solutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 8.2 M | 6.8 M | |
| Total Revenue | 26 M | 19.1 M | |
| Cost Of Revenue | 12.7 M | 9.2 M | |
| Stock Based Compensation To Revenue | 0.08 | 0.05 | |
| Sales General And Administrative To Revenue | 0.43 | 0.47 | |
| Research And Ddevelopement To Revenue | 0.33 | 0.18 | |
| Capex To Revenue | 0.08 | 0.12 | |
| Revenue Per Share | 5.40 | 5.67 | |
| Ebit Per Revenue | (1.00) | (0.95) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Streamline Health Piotroski F Score and Streamline Health Altman Z Score analysis. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (2.35) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.